This proposal is part of an overall company cost reduction effort. Company plans call for possible expansion of the plant's product lines to include cardiovascular, oncological and certain other diagnostic products. Zone procedures would exempt Sanofi Winthrop from Customs duty payments on foreign materials used in production at the McPherson plant for export. The application indicates that zone savings will help improve the plant's international competitiveness. In accordance with the Board's regulations, a member of the FTZ Staff has been designated examiner to investigate the application and report to the Board.
Public comment is invited from interested parties.
The closing period for their receipt is August 17, 1993. John J. Da Ponte, Jr., Executive Secretary.